HYDRASHIFT 2 4 daratumumab 20 tests 4639

GUDID 03607360046395

SEBIA

Multiple clinical chemistry protein IVD, reagent
Primary Device ID03607360046395
NIH Device Record Keydae027af-0127-45a9-86b1-363f96a78250
Commercial Distribution StatusIn Commercial Distribution
Brand NameHYDRASHIFT 2 4 daratumumab 20 tests
Version Model Number4639
Catalog Number4639
Company DUNS276801933
Company NameSEBIA
Device Count1
DM Exemptfalse
Pre-market Exemptfalse
MRI Safety StatusLabeling does not contain MRI Safety Information
Human Cell/Tissue Productfalse
Device Kittrue
Device Combination Productfalse
Single Usefalse
Lot Batchtrue
Serial Numberfalse
Manufacturing Datetrue
Expiration Datetrue
Donation Id Numberfalse
Contains Natural Rubber Latexfalse
Labeled No Natural Rubber Latexfalse
RX Perscriptiontrue
OTC Over-The-Counterfalse

Operating and Storage Conditions

Storage Environment TemperatureBetween 2 Degrees Celsius and 8 Degrees Celsius

Device Identifiers

Device Issuing AgencyDevice ID
GS103607360046395 [Primary]

FDA Pre-market Approvals/Notifications & deNovo

FDA Product Code

CFFImmunoelectrophoretic, Immunoglobulins, (G, A, M)

Sterilization

Steralize Prior To Usefalse
Device Is Sterilefalse

Device Entry Metadata

Public Version StatusNew
Device Record StatusPublished
Public Version Number1
Public Version Date2019-07-09
Device Publish Date2019-07-01

Devices Manufactured by SEBIA

03607360012444 - CAPILLARYS 3 DBS2024-05-08 INSTRUMENT
03607360025062 - CAPI 3 NEONAT Hb2024-05-08
03607360025635 - CAPI 3 NEONAT HEMOLYSING SOLUTION2024-05-08
03607360025789 - CAPILLARYS 3 DBS MICROPLATES2024-05-08 MICROPLATES ARE AN ACCESSORY _PLASTIC PLATES
03607360047576 - CAPI 3 NEONAT Hb AF Control2024-05-08
03607360047927 - Hb AFSC Control2024-05-08
03607360026014 - ANTISERA CAPI 3 IT (10)2023-12-07
03607360026021 - Sample Diluent CAPI 3 IT (10)2023-12-07

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.